Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Avelox cost?

See the DrugPatentWatch profile for Avelox

How much does a bottle of Avelox usually cost?
Avelox (moxifloxacin) is sold in 500‑mg tablets. A standard 14‑tablet bottle often ranges from $80 to $180 in U.S. pharmacies, depending on the pharmacy, location, and whether the drug is sold in a bulk or single‑tablet format.

What’s the price of the generic version?
Generic moxifloxacin is typically 20‑30 % cheaper than the brand name. A 14‑tablet bottle of the generic usually costs between $60 and $120, offering a noticeable savings for many patients.

Will my insurance cover it?
Most health plans cover moxifloxacin, either as a generic or brand drug. Coverage often requires a prescription and may involve a copay that varies by plan. Check with your insurer or pharmacy benefits manager for exact details.

Can I find cheaper options like discount programs?
Yes. Programs such as manufacturer coupons, pharmacy discount cards, or health‑insurance savings portals can lower out‑of‑pocket costs. Additionally, checking multiple pharmacies or using mail‑order options can yield better prices.

Are there cost differences outside the U.S.?
International prices vary. In Canada, a 14‑tablet bottle of Avelox can range from CAD 70 to CAD 130, while in the UK the same quantity may cost £30–£60, reflecting differences in drug pricing and subsidy systems.

When did the brand patent expire?
The original brand patents for Avelox have long expired, and generic manufacturers have been on the market for several years [1].

What could affect the price?
Price can shift with changes in patent status, generic competition, insurance formularies, and market demand. Periodic drug pricing reviews or new therapeutic alternatives can also influence cost over time.

---

Sources
[1] https://www.drugpatentswatch.com/moxifloxacin



Other Questions About Avelox :

Avelox manufacturer? Generic for avelox? Avelox peak sales? Generic avelox? Buy avelox 400 mg? Avelox generic? Avelox generic name?

AI-Drug Label Prescribing Information Alignment Report

92
92%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI response correctly marked pricing/market claims as absent from the label and did not introduce incorrect label content. A safety-context commentary was included, which is not supported by the provided label content.


Category Scores


Accurate Statements

Pricing/market claims are not present in the label; the label excerpt provided only includes an AVELOX dosing instruction.
LABEL SECTION SCORES and CLAIM EVALUATION indicate all price/market claims are absent_from_label; AVAILABLE LABEL SECTIONS show a single dosing-related line.

Unsupported Statements

The AI response includes safety-context commentary (boxing in boxed warnings, contraindications, etc.) not supported by the provided label excerpt.
The available label sections in the prompt contain only a dosing instruction; there is no explicit safety labeling content presented to support these safety references.

Contradictions


Important Omissions

No evaluation or mapping of the label's safety-related content (contraindications, boxed warnings, pregnancy/pediatric use, dosing safety) is provided beyond noting general safety topics. This omission is material for safety auditing.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The claims evaluated are pricing/market content and do not address patient safety or label-directed risk information. However, the AI response includes a safety-context note that references label sections not present in the supplied excerpt.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Extraneous safety-context commentary not supported by the provided label excerpt; pricing claims correctly identified as non-label content.

Suggested Improvement
Limit evaluation to label content when assessing alignment for price/market claims; if safety content is discussed, explicitly map to actual label sections (e.g., 4 Contraindications, 5 Warnings and Precautions, 8 Use in Specific Populations) and cite them from the given prescribing information.

Drug Brand Mention Assessment

Branding Score
67
Visibility
86
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • Avelox (moxifloxacin) is sold in 500-mg tablets.
  • A standard 14-tablet bottle often ranges from $80 to $180 in U.S. pharmacies.
  • Generic moxifloxacin is typically 20-30% cheaper than the brand name.
  • The original brand patents for Avelox have long expired, and generic manufacturers have been on the market for several years.
Differentiators
  • Brand price is affected by patent status and generic competition.
  • Pricing varies by country (Canada CAD 70–130; UK £30–£60) due to subsidy systems.
  • Discount programs and mail-order options can lower out-of-pocket costs.

Pricing Perception: Not Mentioned